OncoCyte Corporation logo

OncoCyte Corporation

NASDAQ:OCX

Overview | Financials
Company Name OncoCyte Corporation
Symbol OCX
Currency USD
Price 2.67
Market Cap 35,683,482
Dividend Yield 0%
52-week-range 2.08 - 4.86
Industry Biotechnology
Sector Healthcare
CEO Mr. Joshua Riggs
Website https://oncocyte.com

An error occurred while fetching data.

About OncoCyte Corporation

OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing,

Related Stocks

Shattuck Labs, Inc. logo

Shattuck Labs, Inc.

STTK

7.24 USD

MediciNova, Inc. logo

MediciNova, Inc.

MNOV

1.35 USD

MDxHealth SA logo

MDxHealth SA

MDXH

2.375 USD

Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

JSPR

24.22 USD

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

5.09 USD

Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc.

OLMA

9.65 USD

Financials

Numbers are in millions USD

Numbers are in millions USD